Written questions by Morgan.

What recent assessment his Department has made of the potential impact of the requirement to dispose of unused specialist invalid food products as medical waste on level of food waste.

Through the implementation of the NHS Clinical Waste Strategy and the National Standards for Healthcare Food and Drink, NHS England is actively working to reduce both clinical and food waste across the system. The Clinical Waste Strategy promotes appropriate waste segregation and treatment to minimise unnecessary incineration and environmental harm. Meanwhile, the food standards encourage healthcare providers to reduce food waste through improved planning, monitoring, and sustainable practices. It is widely accepted that any medication that is provided via clinical provision should be disposed of as offensive waste. Any unused food products that are still in their packaging can be disposed of through the agreed food waste system. NHS England continues to monitor the implementation of these strategies and welcomes further evidence or insights that could inform future assessments or policy development in this area.

Whether she plans to include Shrewsbury and Telford Hospital NHS Trust in the National maternity and neonatal investigation; and whether she plans to include bereaved families in Shropshire in the investigation.

The Chair of the Independent Maternity and Neonatal Investigation, Baroness Amos, has removed the Shrewsbury and Telford Hospital NHS Trust from the list of local National Health Service trust investigations for the Independent National Maternity and Neonatal Investigation following recent discussions with West Mercia Police about the details and schedule of their ongoing investigation.The call for evidence will launch in November, and families from Shrewsbury and Telford have been encouraged to participate.

What steps his Department is taking to support (a) autistic people and (b) their families affected by claims that acetaminophen causes autism.

The Department recognises that recent claims suggesting a link between acetaminophen and autism may have caused concern among some individuals. The Government, my Rt. Hon. Friend, the Secretary of State for Health and Social Care, and I have provided clear reassurance through traditional media and social media channels that there is no evidence to link the use of acetaminophen, also known as paracetamol, by pregnant women to autism in their children. The Medicines and Healthcare products Regulatory Agency swiftly published a press release confirming that taking paracetamol during pregnancy remains safe and there is no evidence it causes autism in children. The press release is available at the following link:https://www.gov.uk/government/news/mhra-confirms-taking-paracetamol-during-pregnancy-remains-safe-and-there-is-no-evidence-it-causes-autism-in-children

What steps his Department is taking to support the public in (a) recognising and (b) rejecting health misinformation.

The Department takes the challenge of health misinformation seriously and recognises its potential impact on public health outcomes. We focus on delivering consistent, clinically assured messaging that builds public trust and confidence, positioning the Department and the National Health Service as reliable sources of health information and advice.

If he will work with (a) autistic people, (b) their families and (c) experts to ensure that public health messaging on autism is (i) accurate, (ii) accessible and (iii) trustworthy.

The Department recognises the importance of providing the public with accurate health information and preventing misinformation. We are also committed to working with people with lived experience of autism to ensure that policies are designed to meet the needs of autistic people and makes their lives better.The Department regularly rebuts factual inaccuracies when they appear in traditional media and undertakes extensive planning, engagement, and strategic work to ensure accurate public health information is available on social media channels to mitigate misinformation. In addition, the Department strives to ensure that the information it publishes is accurate, clear, and accessible to a variety of audiences, including using easy read versions.

What steps he is taking to increase defibrillator training in schools in North Shropshire constituency.

The Department for Education has published guidance on automated external defibrillators (AEDs) for schools, including on maintenance and registration with The Circuit. This guidance is available at the following link:https://assets.publishing.service.gov.uk/media/67936b102de28ea2d392f35b/Automated_External_Defibrillators__AEDs__guidance_for_schools.pdfNHS England provides training sessions on first aid, cardiopulmonary resuscitation (CPR), and the use of AEDs both in the community and in schools, under the under Restart a Heart initiative. NHS England has trained over 35,800 adults and children in CPR and defibrillation.

What steps he is taking to increase awareness of prostate-specific antigen tests among travel insurers.

PSA tests are blood tests that measure the amount of prostate specific antigen (PSA) in blood. Raised levels, often in combination with other symptoms, can be an indication of prostate cancer, though not exclusively. PSA tests have previously been used as a screening tool in asymptomatic populations, but their limitations mean they are not currently recommended for population-level screening. To find better ways of testing for prostate cancer, the Government is investing £16 million into the Prostate Cancer UK-led TRANSFORM screening trial, which aims to identify more effective approaches for detecting prostate cancer earlier.While the Department has no plans to target insurers with information about PSA, the NHS website has clear and accurate information about PSA testing that can be referred to. Where someone has had a PSA test and they are concerned about their travel insurance, they should discuss this directly with their insurers. Different insurers may take a different view of the relevant factors in determining the price of insurance.

What steps he is taking to increase (a) awareness and (b) the availability of Naloxone in public locations.

Naloxone forms a key part of the Government’s plan to reduce drug related deaths, and we are committed to raising awareness of, and expanding access to, naloxone across the country.To expand access to naloxone, in December 2024, the Department amended the Human Medicines Regulations 2012. This legislation enables more services and professionals to supply naloxone, which in turn makes it easier for people at risk to access it. The Department is continuing to work with the other UK nations and front-line services to ensure naloxone reaches all those who need it.We also published guidance on GOV.UK earlier this year that sets out essential practical information such as who can supply naloxone, the products available, how to use naloxone and other basic lifesaving tools, and the training required. This guidance is available at the following link:https://www.gov.uk/guidance/supplying-take-home-naloxone-without-a-prescriptionAs naloxone is a prescription-only medication, only those that are listed in the Human Medicines Regulations 2012 are able to supply naloxone without a prescription. However, the Department is currently considering options to do more in both expanding access to naloxone and raising awareness of the medication.

How many covid-19 vaccinations were available for use in England in winter (a) 2025-6, (b) 2024-5 and (c) 2023-4.

We are unable to provide the information requested, as it is commercially sensitive, however adequate doses were available to deliver the programmes.

What steps he is taking to protect household contacts of the immunosuppressed from covid-19 infection.

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of severe illness, involving hospitalisation and/or death, arising from COVID-19.The JCVI’s advice for autumn 2024 noted that in the era of high population immunity to COVID-19, and with all cases due to highly transmissible Omicron sub-variants, any protection offered by the vaccine against the transmission of infection from one person to another was expected to be extremely limited. On this basis, the JCVI did not advise offering vaccination to household contacts of people with immunosuppression. The Government accepted the JCVI’s advice for autumn 2024, with both the advice and the Government’s response available at the following link:https://www.gov.uk/government/news/government-accepts-advice-on-2024-autumn-covid-vaccine-programmeHousehold contacts were therefore not offered vaccination in the autumn 2024 campaign. On 13 November 2024, the JCVI published advice on the COVID-19 vaccination programme covering vaccination in 2025 and spring 2026. In line with its advice for the autumn 2024 campaign, the JCVI did not advise COVID-19 vaccination for household contacts of people with immunosuppression. This advice is available at the following link:https://www.gov.uk/government/publications/covid-19-vaccination-in-2025-and-spring-2026-jcvi-advice/jcvi-statement-on-covid-19-vaccination-in-2025-and-spring-2026The Government accepted the JCVI’s advice on eligibility for the spring and autumn 2025 COVID-19 vaccination programme. The Government is considering the advice for spring 2026 carefully and will respond in due course.Those with concerns are advised to discuss these with their general practitioner or healthcare professional.

How much capital funding her Department has allocated for the rollout of neighbourhood health centres (a) in England and (b) for each eligible integrated care board.

The Government is committed to delivering a National Health Service that is fit for the future, and we recognise that delivering high quality NHS healthcare requires the right infrastructure in the right places.That is why over the course of our 10-Year Health Plan, we aim to establish a neighbourhood health centre in every community, transforming healthcare access by bringing historically hospital-based services into communities and addressing wider determinants of health through services like debt advice, employment support, and obesity management programmes.Nationwide coverage will take time, and we will start by using public capital to update and refurbish existing, under-used buildings, targeting places where healthy life expectancy is lowest and delivering healthcare closer to home for those that need it the most.Capital funding for neighbourhood health centres will become available from 2026/27, with detailed planning guidance for local systems to be communicated before the end of the year.As outlined in the Government’s 10 Year Infrastructure Strategy, a decision on whether to proceed with the use of Public Private Partnerships for neighbourhood health centres will be made by HM Treasury and relevant ministers by the 2025 Autumn Budget.

Whether his Department has made an assessment of the adequacy of the (a) training and (b) support provided to volunteers who help maintain public use defibrillators.

Charities which provide automated external defibrillators (AED) have clear guidance in place on the use and ongoing maintenance of the devices they provide.The Circuit, the national defibrillator registry independently operated by the British Heart Foundation, notifies the guardian of the defibrillator when it has been used and action to replace the pads is required.In addition, the Department for Education has published guidance on AEDs for schools, including on maintenance and registration with The Circuit. A copy of this guidance is attached.NHS England provides training sessions on first aid, cardiopulmonary resuscitation (CPR), and the use of AEDs both in the community and in schools, under the Restart a Heart initiative. NHS England has trained over 35,800 adults and children in CPR and defibrillation.

Whether his Department has made a recent assessment of the adequacy of the maintenance process of public use defibrillators.

Charities which provide automated external defibrillators (AED) have clear guidance in place on the use and ongoing maintenance of the devices they provide.The Circuit, the national defibrillator registry independently operated by the British Heart Foundation, notifies the guardian of the defibrillator when it has been used and action to replace the pads is required.In addition, the Department for Education has published guidance on AEDs for schools, including on maintenance and registration with The Circuit. A copy of this guidance is attached.NHS England provides training sessions on first aid, cardiopulmonary resuscitation (CPR), and the use of AEDs both in the community and in schools, under the Restart a Heart initiative. NHS England has trained over 35,800 adults and children in CPR and defibrillation.

Whether his Department has made a recent assessment of the adequacy of (a) guidance and (b) other protocols provided to properties with public use defibrillators.

Charities which provide automated external defibrillators (AED) have clear guidance in place on the use and ongoing maintenance of the devices they provide.The Circuit, the national defibrillator registry independently operated by the British Heart Foundation, notifies the guardian of the defibrillator when it has been used and action to replace the pads is required.In addition, the Department for Education has published guidance on AEDs for schools, including on maintenance and registration with The Circuit. A copy of this guidance is attached.NHS England provides training sessions on first aid, cardiopulmonary resuscitation (CPR), and the use of AEDs both in the community and in schools, under the Restart a Heart initiative. NHS England has trained over 35,800 adults and children in CPR and defibrillation.

If he will make an assessment of the potential merits of requiring organisations with public use defibrillators to be provided with a log of use.

Charities which provide automated external defibrillators (AED) have clear guidance in place on the use and ongoing maintenance of the devices they provide.The Circuit, the national defibrillator registry independently operated by the British Heart Foundation, notifies the guardian of the defibrillator when it has been used and action to replace the pads is required.In addition, the Department for Education has published guidance on AEDs for schools, including on maintenance and registration with The Circuit. A copy of this guidance is attached.NHS England provides training sessions on first aid, cardiopulmonary resuscitation (CPR), and the use of AEDs both in the community and in schools, under the Restart a Heart initiative. NHS England has trained over 35,800 adults and children in CPR and defibrillation.

Will he take steps to provide an interim pay increase for social care workers in advance of the implementation of fair pay agreement outcomes in 2028.

We want to get the process of establishing Fair Pay Agreements right to ensure meaningful reform for the adult social care sector. The public consultation launched recently is an important milestone and we encourage all interested parties to respond.In the interim, the Plan to Make Work Pay is already delivering changes to the National Living Wage. A full-time care worker on the National Living Wage received an increase to their gross annual earnings of £1,400 a year from April 2025. The Spending Review 2025 allows for an increase of over £4 billion in additional funding available for ASC in 2028-29 compared to 2025-26. This includes other sources of income available to support adult social care, additional grant funding and an increase in the National Health Service’s contribution to adult social care via the Better Care Fund, in line with the Department’s Spending Review settlement.Additionally, the Government has committed to reforms which will mitigate the growing pressures on local government services and achieve better value for money.Finally, we are taking forward other significant reforms to the social care sector directly, including expanding the Care Workforce Pathway – the first ever national career structure for adult social care – and providing £12 million of funding for eligible care staff to complete courses and qualifications, such as the Level 2 Adult Social Care Certificate.

Whether his Department has made an assessment of the adequacy of the system used to alert volunteers when a defibrillator is used.

The Department has not made an assessment. The Circuit, the national defibrillator registry, is independently operated by the British Heart Foundation. The Circuit notifies the guardian of the defibrillator when it has been used and action to replace the pads is required.

What recent assessment he has made of the potential impact of clinical oncology workforce shortages on the adoption of innovative cancer treatments by NHS trusts.

We are building out the cancer workforce. As of June 2025, there are over 1,800 full time equivalent doctors working in the speciality of clinical oncology in National Health Service trusts and other core organisations in England. This is almost 440, or 31.5%, more than in 2020.Following additional investment through recent Spending Review settlements, trainees across 16 cancer-related specialties, including clinical and medical oncology, increased from 623 to 773 per year, a 24% increase.To grow the workforce, NHS England has been expanding specialty training places in key cancer professions. Targeted national campaigns and outreach activities, for example in clinical oncology, also promote cancer career pathways, with a focus on increasing applications to under-supplied professions.Training academies in imaging, endoscopy, and genomics are being delivered across regions to provide intensive skills development and to support new models of care, including for cancer patients. Ongoing investment in practice education enhances clinical supervision, education, and training across the cancer and diagnostic workforces, increases placement capacity, supports staff retention, and contributes to high-quality patient care.The adoption of innovative cancer treatments is often clinician-led and self-identified, with doctors seeking out specialist training opportunities themselves. This may include overseas fellowships or short courses, after which skills are cascaded locally through continuing professional development, multidisciplinary teams, and peer-to-peer learning. NHS England supports this through centrally underwritten study leave budgets. In addition, through curriculum reform, selected innovations are incorporated into formal training programmes, ensuring that some advances move from self-directed uptake into nationally standardised education.

What assessment he has made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home.

The National Health Service delivers a range of treatments for cancer, with expert clinicians working with patients to determine the most appropriate option. The Government is working with NHS England to ensure that the most effective treatments are available to patients across the country when they need them.Stereotactic ablative body radiotherapy (SABR) is routinely available to treat several types of cancer, including some types of lung cancer, pancreatic cancer, and liver cancer. Every NHS trust that is commissioned to provide radiotherapy services in England can offer SABR. However, not all cancer types can be treated with SABR in every radiotherapy service, because some trusts may not host the relevant specialist multi-disciplinary team.No assessment has been made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home. However, in line with the Government’s Health Mission shift from hospital to community, the 10-Year Health Plan committed to deliver more urgent care in the community, in people’s homes, or through neighbourhood health centres by 2035.

What recent assessment he has made of the effectiveness of commissioning arrangements for (a) Molecular Radiotherapy, (b) Stereotactic Ablative Body Radiotherapy and (c) Systemic Anti-Cancer Therapies.

The National Health Service delivers a range of treatments for cancer, with expert clinicians working with patients to determine the most appropriate option. The Government is working with NHS England to ensure that the most effective treatments are available to patients across the country when they need them.Stereotactic ablative body radiotherapy (SABR) is routinely available to treat several types of cancer, including some types of lung cancer, pancreatic cancer, and liver cancer. Every NHS trust that is commissioned to provide radiotherapy services in England can offer SABR. However, not all cancer types can be treated with SABR in every radiotherapy service, because some trusts may not host the relevant specialist multi-disciplinary team.No assessment has been made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home. However, in line with the Government’s Health Mission shift from hospital to community, the 10-Year Health Plan committed to deliver more urgent care in the community, in people’s homes, or through neighbourhood health centres by 2035.